Litcius/Paper detail

Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori, Ewa Gniazdowska

2020International Journal of Molecular Sciences318 citationsDOIOpen Access PDF

Abstract

Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune diseases. In this paper, we take an overview of the present state of knowledge with regards to complex mechanisms of methotrexate action and its applications as immunosuppressive drug or chemotherapeutic agent in oncological combination therapy. In addition, the issue of the potential benefits of methotrexate in the development of neurological disorders in Alzheimer's disease or myasthenia gravis will be discussed.

Topics & Concepts

MethotrexateMedicineDrugPharmacologyImmunologyCNS Lymphoma Diagnosis and TreatmentPolyomavirus and related diseasesChronic Lymphocytic Leukemia Research
Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers | Litcius